| Miroslav Bosco Zotovic, MD | |
|
68 Physician Dr, Aiken, SC 29801-6388 | |
| (803) 643-1090 | |
| (803) 643-8080 |
| Full Name | Miroslav Bosco Zotovic |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 68 Physician Dr, Aiken, South Carolina |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649388026 | NPI | - | NPPES |
| T39882 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 19863 (South Carolina) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 19863 (South Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sound Physicians Intensivists Of South Carolina Llc | 4385079060 | 2 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in Investigative Ophthalmology & Visual Science (IOVS).
An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.
Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 3 days ago
| Entity Name | Aiken Professional Association Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639479801 PECOS PAC ID: 0446430805 Enrollment ID: O20110202000685 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in Investigative Ophthalmology & Visual Science (IOVS).
An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.
Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20151015001850 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in Investigative Ophthalmology & Visual Science (IOVS).
An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.
Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 3 days ago
| Entity Name | Sound Physicians Intensivists Of South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962045401 PECOS PAC ID: 4385079060 Enrollment ID: O20200128000539 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in Investigative Ophthalmology & Visual Science (IOVS).
An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.
Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miroslav Bosco Zotovic, MD 367 S Gulph Rd, King Of Prussia, PA 19406-3121 Ph: (803) 643-1090 | Miroslav Bosco Zotovic, MD 68 Physician Dr, Aiken, SC 29801-6388 Ph: (803) 643-1090 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in Investigative Ophthalmology & Visual Science (IOVS).
An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.
Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 3 days ago
Kate Barrett Mayes, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 223 Park Ave Se, Aiken, SC 29801 Phone: 803-641-1270 Fax: 803-641-1276 | |
Thomas Mccullough, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 410 University Pkwy Ste 2500, Aiken, SC 29801 Phone: 803-648-7888 Fax: 803-648-3302 | |
Ghulam Murtaza, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 | |
Janet L Utz, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 137 Miracle Drive, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Keifer Dewayne Richardson, PA-C Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 526 Richland Ave W, Aiken, SC 29801 Phone: 803-648-3130 | |
Dr. Weems R Pennington Iii, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Dr. Frank Joseph Mondschein, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 102 Summerwood Way, Aiken, SC 29803 Phone: 803-649-5300 Fax: 803-649-0056 |